Action of three ectopeptidases on corticotropin-releasing factor: Metabolism and functional aspects

Neuropsychopharmacology

Volumn 28, Issue 1, 2003, Pages 22-33

  Ritchie, James C ^a,b   Davis, Thomas P ^c   Nemeroff, Charles B ^b  

^a Department of Pathology and Laboratory Medicine ^*  (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Aminopeptidase N; Angiotensin converting enzyme; Corticotropin releasing factor; Ectopeptidases; Extracellular processing; Neprilysin

Indexed keywords

BESTATIN; CAPTOPRIL; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; GLYCOPEPTIDE; LEUCINE; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; PHOSPHORAMIDON; PROTEINASE INHIBITOR; TETRAHYDROTHIOPHENE; THIOPHENE DERIVATIVE;

ALGORITHM; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BRAIN CORTEX; CELL CULTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOPHYSIS; HYPOTHALAMUS; IN VITRO STUDY; KINETICS; MALE; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADRENOCORTICOTROPIC HORMONE; ALGORITHMS; AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, CD13; CAPTOPRIL; CELLS, CULTURED; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOTROPIN-RELEASING HORMONE; GLYCOPEPTIDES; HYPOTHALAMUS; KINETICS; LEUCINE; MALE; MOLECULAR SEQUENCE DATA; NEPRILYSIN; PEPTIDYL-DIPEPTIDASE A; PITUITARY GLAND; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; THIOPHENES;

EID: 0037209216     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300014     Document Type: Article

References (42)

1. Almenoff J, Orlowski M (1983). Membrane-bound kidney neutral endopeptidase: interaction with synthetic substrates, naturalpeptides, and inhibitors.Biochemistry2: 590-599.
2. Brooks SPJ (1992). A simple Computer program with statistical tests for the analysis of enzyme kinetics.Biotechniques13: 906-911.
3. Bruhn TO, Engeland WC, Anthony ELP, Gann DS, Jackson IMD (1987).Corticotropin-releasing factor in dog adrenal medulla issecreted in response to hemorrhage.Endocrinology120: 25-33.
4. Catalan R, Gallart JM, Castellanos RM, Galard R (1998). Plasma corticotropin-releasing factor in depressive disorders.BiolPsychiatry44: 15-20.
5. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson Cet al(1986). Alterations in CRF-like immunoreactivity indiscrete brain regions after acute and chronic stress.J Neurosci6: 2908-2914.
6. Childs GV, Morell JL, Niendorf A, Aguilera G (1986). Cytochemical studies of corticotropin-releasing factor (CRF) receptors inanterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis of [biotinyl-Ser1] CRF.Endocrinology119:2129-2142.
7. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EFet al(1993). Corticotropin-releasing hormone in synovialfluid and tissues of patients with rheumatoid arthritis andosteoarthritis.J Immunology151: 1587-1596.
8. Dathe M, Fabian H, Gast K, Zirwer D, Winter R, Beyermann Met al(1996). Conformational differences of ovine and humancorticotropin releasing hormone: A CD, IR, NMR and dynamiclight scattering study.Int J Pept Protein Res47: 383-393.
9. Davis TP, Schoemaker H, Chen A, Yamamura HI (1982).High performance liquid chromatography of pharmacologicallyactive amines and peptides in biological materials.Life Sci30:971-987.
10. Diamant M, De Wied D (1993). Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrineand autonomic activity.Neuroendocrinology57: 1071-1081.
11. Ellis MJ, Schmidli RS, Donald RA, Livesey JH, Espiner EA (1990).Plasma corticotropin-releasing factor and vasopressinresponses to hypoglycemia in normal man.ClinEndocrinol32:93-100.
12. Fisher LA, Brown MR (1984). Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influenceneuroendocrine and cardiovascular function.Brain Res296:41-47.
13. Fossiez F, Lemay G, Labonte N, Parmentier-Lesage F, Boileau G, Crine P (1992).Secretion of a functional soluble form of neutralendopeptidase-24.11 from a baculovirus-infected insect cell line.Biochem J284: 53-59.
14. Ghaddar G, Ruchon AF, Carpentier M, Marcinkiewicz M, Seidah NG, Crine Pet al(2000). Molecular cloning and biochemicalcharacterization of a new mouse testis soluble-zinc-metallopep-tidase of the neprilysin family.Biochem J347: 419-429.
15. Glowinski J, Iversen LL (1966). Regional studies of catecholamines in the rat brain.J Neurochem13: 665-669.
16. Kenny J (1993). Neuropeptide processing and metabolism: molecular and clinical aspects.BiochemSoc Trans21: 663-668.
17. Kertscher U, Beyermann M, Krause E, Furkert J, Berger H, Bienert Met al(1998). The degradation of corticotropin-releasing factorby enzymes of the rat brain studied by liquid chromatography-mass spectrometry.Peptides19: 649-658.
18. Kiryu-Seo S, Sasaki M, Yokohama H, Nakagomi S, Hirayama T, Aoki Set al(2000). Damage-induced neuronal endopeptidase(DINE) is a unique metallopeptidase expressed in response toneuronal damage and activates superoxide scavengers.ProcNatlAcadSci USA97: 4345-4350.
19. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EBet al(1995). Cloning and characterization of afunctionally distinct corticotropin-releasing factor receptorsubtype from rat brain.ProcNatlAcadSci USA 92: 836-840.
20. Morley JE, Levine AS (1982). Corticotropin-releasing factor, grooming and ingestive behavior.Life Sci31: 1459-1464.
21. Nomizu M, Miyamoto M (1989). Convulsant peptides related to corticotropin-releasing factor (CRF).Brain Res505: 326-328.
22. Orth DN, Nicholson WE (1977).Different molecular forms of ACTH.Ann NY AcadSci297: 27-46.
23. Petrusz P, Merchenthaler I, Ordronneau P Maderdrut JL, Vigh S, Schally AV (1984). Corticotropin-releasing factor (CRF)-like immunoreactivity in the gastro-entero-pancreatic endocrine system.Peptides5: 71-78.
24. Potter E, Behan D, Fischer W, Linton EA, Lowry PJ, Vale WW (1991). Cloning and characterization of the cDNAs for humanand rat corticotropin-releasing factor-binding proteins.Nature349: 423-426.
25. Ritchie JC, Owens MJ, O’Connor LW, Kegelmeyer AE, Walker JT, Stanley M etal(1986). Measurement of ACTH and CRFimmunoreactivity in adrenal gland and lymphocytes.SocNeurosciAbstr12: 1041.
26. Rivier J, Rivier C, Vale W (1984). Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in therat.Science224: 889-891.
27. Romier C, Bernassau JM, Cambillau C, Darbon H (1993). Solution structure of human corticotropin-releasing factor by1H NMRand distance geometry with restrained molecular dynamics.Protein Eng6: 149-156.
28. Rossomando EF (1989). Application of high-performance liquid chromatography to enzyme activity determination.J Chromatogr492: 361-375.
29. Sasaki A, Liotta AS, Luckey MM, Margioris AN, Suda T Krieger DT (1984).Immunoreactivecorticotropin-releasingfactor is present in human maternal plasma during thethird trimester of pregnancy.J ClinEndocrinolMetab59:812-814.
30. Skidgel RA, Erdos EG (1985). Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH terminaltripeptides from luteinizing hormone-releasing hormone.ProcNatlAcadSci USA82: 1025-1029.
31. Smith AI, Engler D, Fullerton ML, Pham J, Wallace C, Morgan FJet al(1987). Post-translational processing of corticotropin-releas-ing factor in the ovine tuberoinfundibular system and pituitary.Ann N Y AcadSci512: 24-47.
32. Stephanou A, Jessop DS, Knight RA, Lightman SL (1990).Corticotropin-releasing factor-like immunoreactivity and mRNAin human leukocytes.Brain BehavImmun4: 67-73.
33. Stephenson SL, Kenny AJ (1987). The hydrolysis of a-human atrial natriuretic peptide by pig kidney microvillarmem-branes is initiated by endopeptidase 24-11.Biochem J243:183-187.
34. Suda T, Tomori N, Tozawa F, Demura H, Shizume K, Mouri Tet al(1984). Immunoreactivecorticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lungcancer and pheochromocytoma.J ClinEndocrinol Metab58:919-924.
35. Turner AJ, Isaac RE, Coates D (2001). The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function.Bioessays23: 261-269.
36. Valdenaire O, Grayson RJ, Faull RLM, Schweizer A (1999). XCE, a new member of the endothelin-converting enzyme and neutralendopeptidase family, is preferentially expressed in the CNS.Mol Brain Res64: 211-221.
37. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson Let al(1983a). Chemical and biological characterization of corticotro-pin-releasing factor.RectProgHorm Res39: 245-270.
38. Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton Det al(1983b). Assay of corticotropin-releasing factor. In: ConnPM (ed).Methods in Enzymology.Academic Press: New York, Vol 103: pp 565-577.
39. Vale W, Spiess J, Rivier C, Rivier J (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulatessecretion of corticotropin and B-endorphin.Science213:1394-1397.
40. Valentino RL, Martin DL, Suzuki M (1986). Dissociation of locus coeruleus activity and blood pressure: effects of clonidineand corticotropin-releasing factor.Neuropharmacology25:603-610.
41. Yoon DJ, Sklar C, David R (1988). Presence of immunoreactivecorticotropin-releasing factor in rat testis.Endocrinology122:759-761.
42. Zacharieva S, Matrozov P, Stoeva I, Andonova K (1991). The effect of angiotensin-converting enzyme inhibition on ACTH responseto corticotropin-releasing hormone (CRH) in normal men.HormMetab Res23: 245-246.